Skip to content
★ Sign in to follow
NM
Total declarations
26
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 22 Sept 2025 for Myriad Genetics INC, €6,369.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

Natalie Munk: trading record in brief

This profile gathers the share dealings of Natalie Munk in Myriad Genetics Inc. We count 26 filings; the first trade dates from 25 August 2022 and the latest from 21 September 2025.

Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Most recently, on 22 September 2025, the filings show a share grant worth €6,369 in Myriad Genetics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Natalie Munk

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total
  • ◆
    Chief Accounting OfficerExecutivesMyriad Genetics Inc
    7,475 USD20SEC
    962 shares@ US$7.776.7% of flowCommon StockSEC:0001932320-25-000006:0
  • ◆
    Chief Accounting OfficerExecutivesMyriad Genetics Inc
    3,522 USD19SEC
    362 shares@ US$9.733.4% of flowCommon StockSEC:0001932320-25-000002:0
  • ◆
    Chief Accounting OfficerExecutivesMyriad Genetics Inc
    4,284 USD19SEC
    428 shares@ US$10.014.2% of flowCommon StockSEC:0001628280-25-014728:0
  • ◆
    Chief Accounting OfficerExecutivesMyriad Genetics Inc
    0SEC
    4,000 shares0Common StockSEC:0001628280-25-013154:0
  • ◆
    Chief Accounting OfficerExecutivesMyriad Genetics Inc
    0SEC
    3,316 shares0Common StockSEC:0001628280-25-010140:0
  • ◆
    Chief Accounting OfficerExecutivesMyriad Genetics Inc
    26,645 USD22SEC
    964 shares@ US$27.6425.2% of flowCommon StockSEC:0001932320-24-000008:0
  • ◆
    Chief Accounting OfficerExecutivesMyriad Genetics Inc
    6,102 USD20SEC
    217 shares@ US$28.125.8% of flowCommon StockSEC:0001932320-24-000006:0
  • ◆
    Chief Accounting OfficerExecutivesMyriad Genetics Inc
    11,771 USD20SEC
    581 shares@ US$20.2611.5% of flowCommon StockSEC:0001932320-24-000004:0
  • ◆
    Chief Accounting OfficerExecutivesMyriad Genetics Inc
    7,979 USD20SEC
    363 shares@ US$21.987.8% of flowCommon StockSEC:0001932320-24-000002:0
  • ◆
    Chief Accounting OfficerExecutivesMyriad Genetics Inc
    8,073 USD20SEC
    363 shares@ US$22.247.8% of flowCommon StockSEC:0001628280-24-012919:0
  • ◆
    Chief Accounting OfficerExecutivesMyriad Genetics Inc
    0SEC
    7,500 shares0Common StockSEC:0001628280-24-011687:0
  • ◆
    Chief Accounting OfficerExecutivesMyriad Genetics Inc
    0SEC
    10,000 shares0Common StockSEC:0001932320-23-000005:0
  • ◆
    Chief Accounting OfficerExecutivesMyriad Genetics Inc
    3,859 USD19SEC
    218 shares@ US$17.703.8% of flowCommon StockSEC:0001932320-23-000003:0
  • ◆
    Chief Accounting OfficerExecutivesMyriad Genetics Inc
    9,583 USD20SEC
    404 shares@ US$23.729.3% of flowCommon StockSEC:0001628280-23-009266:0
  • ◆
    Chief Accounting OfficerExecutivesMyriad Genetics Inc
    8,889 USD20SEC
    388 shares@ US$22.918.7% of flowCommon StockSEC:0001628280-23-009055:0
  • ◆
    Chief Accounting OfficerExecutivesMyriad Genetics Inc
    0SEC
    6,000 shares0Common StockSEC:0001628280-23-008317:0
  • ◆
    Chief Accounting OfficerExecutivesMyriad Genetics Inc
    5,476 USD20SEC
    220 shares@ US$24.895.8% of flowCommon StockSEC:0001628280-22-023764:0

17 of 17 declarations